STING1 and myeloid sarcoma: This takes into account that the antiviral drug ganciclovir alleviated EAE by decreasing microglial reactivity in a STING/type I IFN-dependent fashion [32] and that HIV-infected patients showed a lower MS incidence when treated with antiviral drugs [49,50].